CIK: 0001839209 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $611,701 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AMBRX BIOPHARMA INC | 16,688,636 | $274,695 | 44.9% | $8.33 | — | SPONSORED ADS | 02290A102 |
| TGTX | TG THERAPEUTICS INC | 9,278,439 | $230,476 | 37.7% | $15.19 | +70.0% | COM | 88322Q108 |
| ARGX | ARGENX SE | 273,343 | $106,530 | 17.4% | $378.83 | — | SPONSORED ADR | 04016X101 |